Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sarepta Therapeutics Inc shares valued at $205,400 were purchased by Boor Kathryn Jean on Dec 05 ’24. At $125.55 per share, Boor Kathryn Jean acquired 1,636 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Estepan Ian Michael sold 5,985 shares, netting a total of over 822,100 in proceeds. Following the sale of shares at $137.36 each, the insider now holds 33,946 shares.
Before that, Estepan Ian Michael had added 5,985 shares to its account. In a trade valued at $822,130, the Officer bought Sarepta Therapeutics Inc shares for $137.37 each.
As published in a research note from Needham on November 27, 2024, Sarepta Therapeutics Inc [SRPT] has been retained to a Buy and the price target has been revised to $202. Analysts at H.C. Wainwright started covering the stock with ‘”a Sell”‘ outlook in a report released in late November. As of November 07, 2024, Cantor Fitzgerald has increased its “Neutral” rating to a “an Overweight” for SRPT. Earlier on October 21, 2024, Jefferies initiated its rating. Their recommendation was “a Buy” for SRPT stock.
Analyzing SRPT Stock Performance
During the last five days, there has been a drop of approximately -8.45%. Over the course of the year, Sarepta Therapeutics Inc shares have jumped approximately 30.96%. Shares of the company reached a 52-week high of $173.25 on 06/21/24 and a 52-week low of $91.34 on 01/05/24. A 50-day SMA is recorded $122.38, while a 200-day SMA reached $129.98. Nevertheless, trading volume fell to 0.61 million shares from 0.47 million shares the previous day.
Support And Resistance Levels for Sarepta Therapeutics Inc (SRPT)
According to the 24-hour chart, there is a support level at 124.51, which, if violated, would cause prices to drop to 122.74. In the upper region, resistance lies at 127.96. The next price resistance is at 129.64. RSI (Relative Strength Index) is 54.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 6.66, which suggests the price will increase in the coming days. Percent R is at 34.18%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
